Bi-allelic truncating variants in CASP2 underlie a neurodevelopmental disorder with lissencephaly
Authors:
Open Access
- 26 October 2023
- journal article
- research article
- Published by Springer Nature in European Journal of Human Genetics
- Vol. 32 (1) , 52-60
Abstract
Lissencephaly (LIS) is a malformation of cortical development due to deficient neuronal migration and abnormal formation of cerebral convolutions or gyri. Thirty-one LIS-associated genes have been previously described. Recently, biallelic pathogenic variants in CRADD and PIDD1, have associated with LIS impacting the previously established role of the PIDDosome in activating caspase-2. In this report, we describe biallelic truncating variants in CASP2, another subunit of PIDDosome complex. Seven patients from five independent families presenting with a neurodevelopmental phenotype were identified through GeneMatcher-facilitated international collaborations. Exome sequencing analysis was carried out and revealed two distinct novel homozygous (NM_032982.4:c.1156delT (p.Tyr386ThrfsTer25), and c.1174 C > T (p.Gln392Ter)) and compound heterozygous variants (c.[130 C > T];[876 + 1 G > T] p.[Arg44Ter];[?]) in CASP2 segregating within the families in a manner compatible with an autosomal recessive pattern. RNA studies of the c.876 + 1 G > T variant indicated usage of two cryptic splice donor sites, each introducing a premature stop codon. All patients from whom brain MRIs were available had a typical fronto-temporal LIS and pachygyria, remarkably resembling the CRADD and PIDD1-related neuroimaging findings. Other findings included developmental delay, attention deficit hyperactivity disorder, hypotonia, seizure, poor social skills, and autistic traits. In summary, we present patients with CASP2-related ID, anterior-predominant LIS, and pachygyria similar to previously reported patients with CRADD and PIDD1-related disorders, expanding the genetic spectrum of LIS and lending support that each component of the PIDDosome complex is critical for normal development of the human cerebral cortex and brain function.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (469177153)
- Wellcome Trust
- Multiple System Atrophy Trust
- University College London Hospitals NHS Foundation Trust
- Michael J. Fox Foundation for Parkinson’s Research
- Rosetrees Trust
- Ataxia UK
- Brain Research Trust
- Alzheimer’s Research UK
This publication has 50 references indexed in Scilit:
- Structural and Enzymatic Insights into Caspase-2 Protein Substrate Recognition and CatalysisJournal of Biological Chemistry, 2011
- Ocular neuroprotection by siRNA targeting caspase-2Cell Death & Disease, 2011
- Genetic inhibition of caspase‐2 reduces hypoxic‐ischemic and excitotoxic neonatal brain injuryAnnals of Neurology, 2011
- The Human Phenotype Ontology: A Tool for Annotating and Analyzing Human Hereditary DiseaseThe American Journal of Human Genetics, 2008
- A role for caspase 2 and PIDD in the process of p53-mediated apoptosisProceedings of the National Academy of Sciences, 2008
- Crystallization and preliminary X-ray crystallographic studies of the oligomeric death-domain complex between PIDD and RAIDDActa Crystallographica Section F Structural Biology and Crystallization Communications, 2007
- Death Domain Assembly Mechanism Revealed by Crystal Structure of the Oligomeric PIDDosome Core ComplexCell, 2007
- Vision in children with hydrocephalusDevelopmental Medicine & Child Neurology, 2006
- The biochemical mechanism of caspase-2 activationCell Death & Differentiation, 2004
- The PIDDosome, a Protein Complex Implicated in Activation of Caspase-2 in Response to Genotoxic StressScience, 2004